Literature DB >> 27101519

MicroRNAs in hepatic pathophysiology.

Yoshiki Murakami1, Norifumi Kawada1.   

Abstract

MicroRNAs (miRNAs) are a group of small non-coding RNAs that range in length from 20 to 25 nucleotides. MicroRNAs are specific for multiple cellular functions, including cell generation, differentiation, multiplication, carcinogenesis, and apoptosis. Many researchers have recently reported that the aberrant expression of miRNAs in hepatic tissue was related to the pathogenesis of liver disease, including viral hepatitis, hepatocellular carcinoma, and fatty liver disease. Multiple studies have proposed that an analysis of circulating miRNAs may be useful for diagnosing etiologies or staging the progression of liver disease, as well as for therapeutic purposes, for example, nucleic acid therapy. This review summarizes and discusses recent advances in the knowledge of miRNAs for chronic liver diseases, with special interest in viral hepatitis, liver fibrosis, and biomarkers.
© 2016 The Authors. Hepatology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Hepatology.

Entities:  

Keywords:  HBV; HCC; HCV; biomarker; liver fibrosis; miRNA

Year:  2016        PMID: 27101519     DOI: 10.1111/hepr.12730

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  20 in total

1.  MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.

Authors:  Gábor Lendvai; Tímea Szekerczés; Benedek Gyöngyösi; Krisztina Schlachter; Endre Kontsek; Adrián Pesti; Attila Patonai; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2018-11-09       Impact factor: 3.201

Review 2.  Role of circulatory microRNAs in the pathogenesis of hepatitis C virus.

Authors:  Iqra Almas; Samia Afzal; Muhammad Idrees; Muhammad Usman Ashraf; Iram Amin; Muhammad Shahid; Khadija Zahid; Sadia Zahid
Journal:  Virusdisease       Date:  2017-11-27

3.  Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.

Authors:  Risa Uemura; Yoshiki Murakami; Atsushi Hashimoto; Akinari Sawada; Koji Otani; Koichi Taira; Shuhei Hosomi; Yasuaki Nagami; Fumio Tanaka; Noriko Kamata; Hirokazu Yamagami; Tetsuya Tanigawa; Toshio Watanabe; Y-H Taguchi; Yasuhiro Fujiwara
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

4.  Differential miRNA Expression in the Liver of Balb/c Mice Protected by Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria.

Authors:  Mohamed A Dkhil; Saleh A Al-Quraishy; Abdel-Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich
Journal:  Front Microbiol       Date:  2017-01-11       Impact factor: 5.640

5.  MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7.

Authors:  Li-Ying Song; Yu-Tao Ma; Cui-Fang Wu; Chun-Jiang Wang; Wei-Jin Fang; Shi-Kun Liu
Journal:  Biomed Res Int       Date:  2017-08-27       Impact factor: 3.411

6.  Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.

Authors:  Bao-Min Shi; Wen Lu; Kun Ji; Yu-Feng Wang; Shuai Xiao; Xiu-Yan Wang
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

7.  Inositol-Requiring Enzyme 1 Alpha Endoribonuclease Specific Inhibitor STF-083010 Alleviates Carbon Tetrachloride Induced Liver Injury and Liver Fibrosis in Mice.

Authors:  Qian-Qian Chen; Cheng Zhang; Ming-Qiang Qin; Jian Li; Hua Wang; De-Xiang Xu; Jian-Qing Wang
Journal:  Front Pharmacol       Date:  2018-11-27       Impact factor: 5.810

Review 8.  Viral hepatitis and liver cancer.

Authors:  Marc Ringelhan; Jane A McKeating; Ulrike Protzer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

9.  Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively.

Authors:  Junming Chen; Yongmei Xia; Xiaochen Sui; Qingrui Peng; Tongtong Zhang; Jian Li; Jue Zhang
Journal:  Oncotarget       Date:  2018-05-29

10.  Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track.

Authors:  Sara A El-Wakeel; Rania M Rahmo; Hanan S El-Abhar
Journal:  Sci Rep       Date:  2018-09-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.